BRIEF—US biosimilars market report

South Korea’s Samsung Bioepis today released the Fourth Quarter 2023 Biosimilar Market Report which explores latest market trends for all biosimilars commercially available in the USA.

This latest quarterly report details the recent prices of all biosimilars based on the fourth quarter 2023 average sales price (ASP) published by the Center of Medicare, Medicaid Services (CMS), as well as the market share and price trends of all molecules for which biosimilars are available, providing up-to-date trends ever since the first biosimilar entered market for each category.

Samsung Bioepis Biosimilar Market Report, which was first published in April 2023, is being published every quarter after the CMS publishes updated ASP values for each product.

. To access the full report, please visit  HERE.